Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

January-February 2025; Volume 39,Issue 1

Reviews

  • Open Access
    Mammary Cancer Models: An Overview from the Past to the Future
    JESSICA SILVA, PAULA A. OLIVEIRA, JOSÉ ALBERTO DUARTE and ANA I. FAUSTINO-ROCHA
    In Vivo January 2025, 39 (1) 1-16; DOI: https://doi.org/10.21873/invivo.13800
  • Open Access
    Microbiome and Mucosal Immunity in the Intestinal Tract
    HANNES AHREND, ANJA BUCHHOLTZ and MATTHIAS B. STOPE
    In Vivo January 2025, 39 (1) 17-24; DOI: https://doi.org/10.21873/invivo.13801
  • Open Access
    A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation
    ALFREDO COLOMBO, PORRETTO MARIA CONCETTA, VITTORIO GEBBIA, DANIELA SAMBATARO, GIUSEPPINA SCANDURRA and MARIA ROSARIA VALERIO
    In Vivo January 2025, 39 (1) 25-36; DOI: https://doi.org/10.21873/invivo.13802
  • Open Access
    The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator
    MARTIN PALKOVSKY, NIKOL MODRACKOVA, VERA NEUZIL-BUNESOVA, MARIAN LIBERKO and RENATA SOUMAROVA
    In Vivo January 2025, 39 (1) 37-54; DOI: https://doi.org/10.21873/invivo.13803

Experimental Studies

  • Open Access
    Correlation of Preclinical In Vivo Imaging Modalities and Immunohistochemistry for Tumor Hypoxia and Vasculature
    REBECCA A. D’ALONZO, SYNAT KEAM, TRACY S. HOANG, SUKI GILL, PEJMAN ROWSHANFARZAD, ANNA K. NOWAK, ALISTAIR M. COOK and MARTIN A. EBERT
    In Vivo January 2025, 39 (1) 55-79; DOI: https://doi.org/10.21873/invivo.13804
  • Open Access
    In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models
    TADASHI ASHIZAWA, AKIRA IIZUKA, AKARI KANEMATSU, TAKAYUKI ANDO, CHIE MAEDA, HARUO MIYATA, KAZUE YAMASHITA, TOMOATSU IKEYA, YASUFUMI KIKUCHI, KOUJI MARUYAMA, TAKESHI NAGASHIMA, KENICHI URAKAMI, KEN YAMAGUCHI and YASUTO AKIYAMA
    In Vivo January 2025, 39 (1) 80-95; DOI: https://doi.org/10.21873/invivo.13805
  • Open Access
    Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma
    ADAM THOMAS CRISTAUDO, SHOMA BARAT, NIMA AHMADI and DAVID MORRIS
    In Vivo January 2025, 39 (1) 96-101; DOI: https://doi.org/10.21873/invivo.13806
  • Open Access
    The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo
    SEI MORINAGA, MING ZHAO, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo January 2025, 39 (1) 102-109; DOI: https://doi.org/10.21873/invivo.13807
  • Open Access
    Potential Contribution of Epithelial Growth Factor Receptor to PI3K/AKT Pathway Dysregulation in Canine Soft Tissue Sarcoma
    ALFARISA NURURROZI, MASAYA IGASE, KYOHEI MIYANISHI, MASASHI SAKURAI, YUSUKE SAKAI, MIKA TANABE and TAKUYA MIZUNO
    In Vivo January 2025, 39 (1) 110-119; DOI: https://doi.org/10.21873/invivo.13808
  • Open Access
    Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo January 2025, 39 (1) 120-126; DOI: https://doi.org/10.21873/invivo.13809
  • Open Access
    Perfusion Instability During Hyperthermic Intraperitoneal Chemotherapy: The Utility of a Problem-solving Flowchart
    CHIARA SOLIGO, CAROLA CENZI, FRANCESCA FOSCARO, BEATRICE BORDIGNON, SUSANNA SAVI, PAOLO PERDONÒ, GIANNI MUNARETTO, FRANCESCA VISENTIN, TOMMASO TARANTINO, ALBERTO CERATO, PIERLUIGI PILATI, ROBERTA CABIANCA and ANTONIO SOMMARIVA
    In Vivo January 2025, 39 (1) 127-131; DOI: https://doi.org/10.21873/invivo.13810
  • Open Access
    Therapeutic Potential of Dimethyl Sulfoxide via Subconjunctival Injection in a Diabetic Retinopathy Rat Model
    JIYI HWANG, JI SEUNG JUNG, DONGHEE KIM, MYEONGJEE KWON, JUNGYEON YONG, HAERIN YOON and KYUNG-MEE PARK
    In Vivo January 2025, 39 (1) 132-145; DOI: https://doi.org/10.21873/invivo.13811
  • Open Access
    Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease
    HECTOR KATIFELIS, STAMATIKI GRAMMATIKAKI, ROUBINI ZAKOPOULOU, ARISTOTELIS BAMIAS, MICHALIS V. KARAMOUZIS, KONSTANTINOS STRAVODIMOS and MARIA GAZOULI
    In Vivo January 2025, 39 (1) 146-151; DOI: https://doi.org/10.21873/invivo.13812
  • Open Access
    Impact of DNA Ligase 1 Genotypes on Childhood Acute Lymphocytic Leukemia
    PEI-CHEN HSU, CHAO-CHUN CHEN, HUNG-WEN TSAI, WEN-SHIN CHANG, JEN-SHENG PEI, YUN-CHI WANG, MENG-LIANG LIN, JIE-LONG HE, SHIH-SHUN CHEN, CHIA-WEN TSAI and DA-TIAN BAU
    In Vivo January 2025, 39 (1) 152-159; DOI: https://doi.org/10.21873/invivo.13813
  • Open Access
    The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: A Preliminary Report
    TOÀN MINH NGÔ, TAMÁS NAGY, ZOLTÁN SZOBOSZLAI, CSABA CSIKOS, NOÉMI DÉNES, ANDREA FURKA, GYÖRGY TRENCSÉNYI and ILDIKÓ GARAI
    In Vivo January 2025, 39 (1) 160-171; DOI: https://doi.org/10.21873/invivo.13814
  • Open Access
    Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus
    CHIEN-CHUNG KUO, CHUN-HAO TSAI, FU-KAI CHUANG, YUN-CHI WANG, MEI-CHIN MONG, YA-CHEN YANG, HOU-YU SHIH, SHIH-WEI HSU, WEN-SHIN CHANG, DA-TIAN BAU and CHIA-WEN TSAI
    In Vivo January 2025, 39 (1) 172-179; DOI: https://doi.org/10.21873/invivo.13815
  • Open Access
    Coenzyme Q10 Alleviates Silicosis Fibrosis via Inhibiting Ferroptosis in Mice
    YUE SUN, MENGXUE YU, HUNING ZHANG, WENYUE ZHANG, SHENGPENG WEN, SIRONG CHANG, FEI YANG, GUANGJUN QI, XIN MA, ZHIHONG LIU, ANNING YANG, YIDENG JIANG and BIN LIU
    In Vivo January 2025, 39 (1) 180-189; DOI: https://doi.org/10.21873/invivo.13816
  • Open Access
    Sertaconazole, an Imidazole Antifungal Agent, Suppresses the Stemness of Breast Cancer Cells by Inhibiting Stat3 Signaling
    SU-LIM KIM, WON-KYUNG HONG, HACK SUN CHOI and DONG-SUN LEE
    In Vivo January 2025, 39 (1) 190-200; DOI: https://doi.org/10.21873/invivo.13817
  • Open Access
    3-Bromo-4,5-dihydroxybenzaldehyde Attenuates Allergic Contact Dermatitis by Generating CD4+Foxp3+ T cells
    SANG-CHUL HAN, JUNG-IL KANG, YOUN KYUNG CHOI, DA HEE YANG, KI JU KIM, HA JEONG BOO, WEON-JONG YOON, HEE-KYOUNG KANG, EUN-SOOK YOO and HYE-JIN BOO
    In Vivo January 2025, 39 (1) 201-209; DOI: https://doi.org/10.21873/invivo.13818
  • Open Access
    Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases
    SAYAKA KIHARA, SHINGO OHIRA, NAOYUKI KANAYAMA, TOSHIKI IKAWA, SHOKI INUI, MASARU ISONO, YUYA NITTA, YOSHIHIRO UEDA, TEIJI NISHIO and KOJI KONISHI
    In Vivo January 2025, 39 (1) 210-217; DOI: https://doi.org/10.21873/invivo.13819
  • Open Access
    Effect of Oral Lactate Administration on Skeletal Muscle Mass in Mice Under Different Loading Conditions
    YOSHITAKA OHNO, MASASHI NAKATANI, YUKI MATSUI, YOHEI SUDA, TAKAFUMI ITO, KOKI ANDO, SHINGO YOKOYAMA and KATSUMASA GOTO
    In Vivo January 2025, 39 (1) 218-227; DOI: https://doi.org/10.21873/invivo.13820
  • Open Access
    Canine Stem Cell-derived Exosomes for Lung Inflammation: Efficacy of Intratracheal Versus Intravenous Administration in an Acute Lung Injury Mouse Model
    HA-NA OH, YOU-SEOK KIM, GA-HYUN LIM, JAE-BONG MOON, TAE-HONG YOON, SUNG-YOUL KIM and JU-HYUN AN
    In Vivo January 2025, 39 (1) 228-235; DOI: https://doi.org/10.21873/invivo.13821
  • Open Access
    Evaluation of the Alkaloids as Inhibitors of Human Acetylcholinesterase by Molecular Docking and ADME Prediction
    DENISA CLAUDIA NEGRU, SIMONA GABRIELA BUNGAU, ADA RADU, DELIA MIRELA TIT, ANDREI-FLAVIUS RADU, DELIA CARMEN NISTOR-CSEPPENTO and PAUL ANDREI NEGRU
    In Vivo January 2025, 39 (1) 236-250; DOI: https://doi.org/10.21873/invivo.13822
  • Open Access
    Unilateral Bleomycin-induced Interstitial Pneumonitis Mouse Model With Both a Healthy and a Diseased Lung
    HIROSHI KODAMA, HARUYUKI TAKAKI, YUTAKA HIRATA, EISUKE UESHIMA, YASUSHI KIMURA, REONA WADA, KEIGO OSUGA and KOICHIRO YAMAKADO
    In Vivo January 2025, 39 (1) 251-256; DOI: https://doi.org/10.21873/invivo.13823
  • Open Access
    Suppression of Bone Formation and Resorption by the Deletion of Complex Gangliosides
    SHOTA ICHIKAWA, YOSHITAKA MISHIMA, MAYU NAGAO, GYOSUKE SAKASHITA, KOICHI FURUKAWA, TAKUMA SATO, KEN MIYAZAWA and KAZUNORI HAMAMURA
    In Vivo January 2025, 39 (1) 257-266; DOI: https://doi.org/10.21873/invivo.13824
  • Open Access
    Preclinical Assessment of Safety and Efficacy of Deferoxamine (DFO)-pretreated Feline Adipose Mesenchymal Stem Cells
    HAILONG TENG, MINKYUNG CHO, ZHIQIANG MA, XINPENG JI, SHIYU JIN, YUZE ZHOU, MEIFU XUAN, HYUN-A SEONG, XIANGZI LI, SEONG-HO CHOI and QIANG LI
    In Vivo January 2025, 39 (1) 267-279; DOI: https://doi.org/10.21873/invivo.13825

Clinical Studies

  • Open Access
    Identification of a T2-hyperintense Perivascular Space in Brain Arteriovenous Malformations
    THOMAS WÄLCHLI, KARTIK DEV BHATIA, WILL GUEST, JEROEN BISSCHOP, LEONARDO OLIJNYK, HANS KORTMAN, PAUL E. CONSTANTHIN, PATRICK NICHOLSON, PHILIPPE P. MONNIER, ARISTOTELIS KALYVAS, ETHAN A. WINKLER, MONCEF BERHOUMA, TIMO KRINGS and IVAN RADOVANOVIC
    In Vivo January 2025, 39 (1) 280-291; DOI: https://doi.org/10.21873/invivo.13826
  • Open Access
    Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization
    FRANZISKA HEITMANN, ALEXEY SUROV, SEBASTIAN CHRIST, CHRISTINE MARCH, MACIEJ PECH, MAXIMILIAN THORMANN and ROBERT DAMM
    In Vivo January 2025, 39 (1) 292-301; DOI: https://doi.org/10.21873/invivo.13827
  • Open Access
    Assessment of Brain Development in Children With Congenital Diaphragmatic Hernia – an Automated Brain Segmentation Approach
    SHERIF A. MOHAMED, LARISSA GÖTZ, VICTOR SAASE, JULIA ELROD, JONATHAN ENDLEIN, MEIKE WEIS and EVA NEUMAIER-PROBST
    In Vivo January 2025, 39 (1) 302-310; DOI: https://doi.org/10.21873/invivo.13828
  • Open Access
    Panoramic Radiographic Analysis of Age- and Sex-related Variations in Upper Mandibular Morphology: Focus on the Condyle, Sigmoid Notch, and Coronoid Process
    FLORIAN DUDDE, MANFRED GIESE, OLIVER SCHUCK, SVEN DUDA and CHRISTINA KRÜGER
    In Vivo January 2025, 39 (1) 311-317; DOI: https://doi.org/10.21873/invivo.13829
  • Open Access
    Efficacy and Safety of Low Molecular Weight Heparin and Mechanical Thromboprophylaxis in Immediate Implant-based Breast Reconstruction: A Retrospective Comparative Analysis
    GAUTHIER ZINNER, JÉRÔME MARTINEAU, GIANG THANH LAM, DANIEL F. KALBERMATTEN and CARLO M. ORANGES
    In Vivo January 2025, 39 (1) 318-324; DOI: https://doi.org/10.21873/invivo.13830
  • Open Access
    Lymphangioleiomyomatosis of the Pelvic Lymph Nodes Detected Incidentally During Surgical Staging of Gynecological Malignancies: Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution
    YURIMI LEE and HYUN-SOO KIM
    In Vivo January 2025, 39 (1) 325-334; DOI: https://doi.org/10.21873/invivo.13831
  • Open Access
    Early Oral Feeding in Patients Undergoing Upper Gastrointestinal Surgery: A Propensity Score-matching Study
    CSENGE PAPP, DÓRA LILI SINDLER, ANDRÁS PALKOVICS, ARMAND CSONTOS, ZOLTÁN SÁNDOR, BALÁZS NÉMETH, ANDRÁS VERECZKEI and ANDRÁS PAPP
    In Vivo January 2025, 39 (1) 335-339; DOI: https://doi.org/10.21873/invivo.13832
  • Open Access
    Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up
    RISA NISHIYAMA, TOSHIYA KAGOO, HIRONORI UENO and AKIHIRO YOKOYAMA
    In Vivo January 2025, 39 (1) 340-345; DOI: https://doi.org/10.21873/invivo.13833
  • Open Access
    Evaluation of Lung Adverse Events Associated With Lenvatinib: A Post-marketing Surveillance Study
    YUKO KANBAYASHI, YUKI KANEKO, MOMOKO KOBAYASHI, HARUKA WAKABAYASHI, TADASHI SHIMIZU and MAYAKO UCHIDA
    In Vivo January 2025, 39 (1) 346-352; DOI: https://doi.org/10.21873/invivo.13834
  • Open Access
    Diagnostic Accuracy and Reliability of CT-based Node-RADS for Esophageal Cancer
    JAKOB LEONHARDI, BENEDIKT SCHNARKOWSKI, MATTHIAS MEHDORN, ANNE-KATHRIN HÖHN, STEFAN NIEBISCH, PATRICK PLUM, DANIEL SEEHOFER, SOLVEIG TIEPOLT, TIMM DENECKE and HANS-JONAS MEYER
    In Vivo January 2025, 39 (1) 353-359; DOI: https://doi.org/10.21873/invivo.13835
  • Open Access
    Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER
    YUKO KANBAYASHI, RIO TOMII, NARU YAMAMOTO, HARUKA WAKABAYASHI, MIKU ANZAI, TADASHI SHIMIZU and MAYAKO UCHIDA
    In Vivo January 2025, 39 (1) 360-366; DOI: https://doi.org/10.21873/invivo.13836
  • Open Access
    Clinicopathological Significance of Claudin-6 Immunoreactivity in Low-grade, Early-stage Endometrioid Endometrial Carcinoma
    YURIMI LEE and HYUN-SOO KIM
    In Vivo January 2025, 39 (1) 367-374; DOI: https://doi.org/10.21873/invivo.13837
  • Open Access
    Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure
    TOMOAKI NISHIKAWA, AKINORI HIGAKI, KEISHO KUROKAWA, KOHEI YOSHIMOTO, RIKAKO HORIE, YASUHISA NAKAO, TOMOKI FUJISAWA, SHIGEHIRO MIYAZAKI, YUSUKE AKAZAWA, TORU MIYOSHI, HIROSHI KAWAKAMI, HARUHIKO HIGASHI, SHUNSUKE TAMAKI, KAZUHISA NISHIMURA, KATSUJI INOUE, SHUNTARO IKEDA and OSAMU YAMAGUCHI
    In Vivo January 2025, 39 (1) 375-380; DOI: https://doi.org/10.21873/invivo.13838
  • Open Access
    Metabolic Syndrome and Somatic Composition: A Large Cross-sectional Analysis
    MASAHIRO MATSUI, AKIRA FUKUDA, SAORI ONISHI, KOSUKE USHIRO, TOMOHIRO NISHIKAWA, AKIRA ASAI, SOO KI KIM and HIROKI NISHIKAWA
    In Vivo January 2025, 39 (1) 381-389; DOI: https://doi.org/10.21873/invivo.13839
  • Open Access
    Detection of Costal Cartilage Fractures on CT Images With Computer-aided Detection System for Rib Fractures
    AMIKO KAYO, NANAE TSUCHIYA, KOJI YONEMOTO, MASATO NAKAMURA, SADAYUKI MURAYAMA, MASAKI UECHI, SHOTA KINJO, MASAKI SATO, HIDEKAZU MOROMIZATO, SHUN TOYOSATO, FUMIKIYO GANAHA, YUKA KAWAKAMI, TAKASHI MATAYOSHI and AKIHIRO NISHIE
    In Vivo January 2025, 39 (1) 390-395; DOI: https://doi.org/10.21873/invivo.13840
  • Open Access
    Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database
    MASAKI FUJIWARA, HIROAKI IKESUE, KENTA YAMAOKA, MAYAKO UCHIDA, YOSHIHIRO UESAWA, NOBUYUKI MUROI and TADASHI SHIMIZU
    In Vivo January 2025, 39 (1) 396-403; DOI: https://doi.org/10.21873/invivo.13841
  • Open Access
    Anamorelin and Conduction Defects: A Literature Review and Analysis of the Japanese Pharmacovigilance Database
    NAOHIRO YABUKI, KEN-ICHI SAKO, TOMOJI MAEDA and NAOHITO IDE
    In Vivo January 2025, 39 (1) 404-410; DOI: https://doi.org/10.21873/invivo.13842
  • Open Access
    Impact of Relative Dose Intensity of Enfortumab Vedotin for Advanced Urothelial Carcinoma
    NOBUKI FURUBAYASHI, TAKAHITO NEGISHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, HARUMICHI KATSUKI and MOTONOBU NAKAMURA
    In Vivo January 2025, 39 (1) 411-418; DOI: https://doi.org/10.21873/invivo.13843
  • Open Access
    Prognostic Impact of Preoperative Left Ventricular Systolic Dysfunction in Older Adult Patients With Gastric Cancer
    KAZUYA TAKABATAKE, SHINICHI SAKURAMOTO, RYOTA KOBAYASHI, TETSURO TORIUMI, GEN EBARA, SEIGI LI, YUTAKA MIYAWAKI, HIROSHI SATO and KEISHI YAMASHITA
    In Vivo January 2025, 39 (1) 419-425; DOI: https://doi.org/10.21873/invivo.13844
  • Open Access
    Effect of Oral Nutritional Supplements Composed of High Protein on Body Weight Loss After Gastrectomy
    SATORU KIKUCHI, NOBUO TAKATA, YOSHIHIKO KAKIUCHI, SHINJI KURODA, HAJIME KASHIMA, SHUNSUKE TANABE, KAZUHIRO NOMA, AYAKO TAKAHASHI, SHUNSUKE KAGAWA and TOSHIYOSHI FUJIWARA
    In Vivo January 2025, 39 (1) 426-432; DOI: https://doi.org/10.21873/invivo.13845
  • Open Access
    Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan
    RINTARO SOGAWA, MASAKAZU HATANO, FUMI NISHIMURA, JUNYA NISHI, AYAKA MATSUOKA, KOTA SHINADA, HARUNA YAMADA, HIROSHI TATEISHI, YOSHITO MIZOGUCHI, AKIRA MONJI and CHISATO SHIMANOE
    In Vivo January 2025, 39 (1) 433-439; DOI: https://doi.org/10.21873/invivo.13846
  • Open Access
    Proactive Symptom Monitoring by Pharmacists Using a Cancer Patient Support App in Out-patient Oral Multi-kinase Inhibitor Therapy: Feasibility Study of a Small Patient Population
    MAKI TODO, SUGURU SHIROTAKE, GO KANEKO, KOJUN OKAMOTO, MASASHI SUGASAWA, MITSUHIKO NAKAHIRA, SHIHO ISHIKAWA, NORIKO WAKUI, YOSHINORI MAKINO and TOSHIAKI SAEKI
    In Vivo January 2025, 39 (1) 440-451; DOI: https://doi.org/10.21873/invivo.13847
  • Open Access
    Comparison of Vitamin D3 Supplementation Doses of 1,000, 2,000, 4,000 and 8,000 IU in Young Healthy Individuals
    MARKETA KRALOVA, MICHAL JIRASKO, EVA DEDECKOVA, HEDVIKA HATAKOVA, PAVEL BROZ, VACLAV SIMANEK, DAVID SLOUKA, LADISLAV PECEN and RADEK KUCERA
    In Vivo January 2025, 39 (1) 452-458; DOI: https://doi.org/10.21873/invivo.13848
  • Open Access
    Pharmacist Intervention in Outpatients With Prostate Cancer Prevents Apalutamide-induced Skin Adverse Events
    KENGO UMEHARA, YOSHITAKA SAITO, SHINYA TAKADA, KAYO YAMAGISHI, NORIKATA TAKADA, SATORU MARUYAMA, TORU HARABAYASHI and HIROKAZU HASHISHITA
    In Vivo January 2025, 39 (1) 459-466; DOI: https://doi.org/10.21873/invivo.13849
  • Open Access
    Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio
    MINEHIKO INOMATA, NAOKI TAKATA, ZENTA SETO, NOZOMU MURAYAMA, KOTARO TOKUI, SEISUKE OKAZAWA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI and SHOKO MATSUI
    In Vivo January 2025, 39 (1) 467-472; DOI: https://doi.org/10.21873/invivo.13850
  • Open Access
    Thrombosis in Children: A Retrospective Study from a Single-center Database
    CRISTIAN SAVA, ALIN IUHAS, ANDREEA BALMOȘ, LARISA NIULAȘ, CRISTIAN MARINĂU, ZSOLT FUTAKI, DIANA BEI, KINGA KOZMA, LADISLAU RITLI and ARIANA SZILAGYI
    In Vivo January 2025, 39 (1) 473-481; DOI: https://doi.org/10.21873/invivo.13851
  • Open Access
    Changes in miRNA Pattern Expression Associated With COVID-19 Severity
    PAOLA B. ZÁRATE-SEGURA, MACARIO MARTÍNEZ-CASTILLO, AARÓN PARIS GARDUÑO-GUTIÉRREZ, J. MANUEL HERNÁNDEZ-HERNÁNDEZ, LUIS JAVIER CANO-MARTÍNEZ, JAIME GARCÍA-MENA, RAMÓN M. CORAL-VÁZQUEZ and FERNANDO BASTIDA-GONZÁLEZ
    In Vivo January 2025, 39 (1) 482-490; DOI: https://doi.org/10.21873/invivo.13852
  • Open Access
    Clinical Outcomes of a Modified Technique Combining Submucosal Turbinectomy and Extended Neural Targeting in Chronic Rhinitis Management
    YU-HSUAN LIN and YUNG-TSUNG CHENG
    In Vivo January 2025, 39 (1) 491-497; DOI: https://doi.org/10.21873/invivo.13853
  • Open Access
    A Time-varying Analysis of General Practice Prescribing in the COVID-19 Era: Lessons from Prescription Dynamics in a Pandemic
    KINAN MOKBEL, KATE EMBLIN, ROB DANIELS, FAHAD ALGHAMDI and LEIGH JACKSON
    In Vivo January 2025, 39 (1) 498-508; DOI: https://doi.org/10.21873/invivo.13854
  • Open Access
    Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers
    CAMELIA FLORINA IOVA, LUCIA GEORGETA DAINA, CODRIN DAN NICOLAE ILEA, HORAŢIU PAUL DOMNARIU, TIMEA CLAUDIA GHITEA and MĂDĂLINA DIANA DAINA
    In Vivo January 2025, 39 (1) 509-523; DOI: https://doi.org/10.21873/invivo.13855
  • Open Access
    Chest Pain at Rest With Unremarkable ECG and Cardiac Enzymes: Case Study Emphasising the Importance of Clinical Suspicion in the Diagnosis of Coronary Artery Disease
    SABRINA GILL, KATE EMBLIN, ROB DANIELS and KINAN MOKBEL
    In Vivo January 2025, 39 (1) 524-531; DOI: https://doi.org/10.21873/invivo.13856
  • Open Access
    Low-dose Imatinib Efficacy in a Gastrointestinal Stromal Tumor Patient With KIT Exon 11 W557_K558 Deletion
    HIROTAKA SUTO, MIYUKI KAWAMURA, MITSUNORI MORITA, HIDEKI SAKAI, TAKUMA ONOE, KYOKO IKEUCHI, KAZUYOSHI KAJIMOTO and KOJI MATSUMOTO
    In Vivo January 2025, 39 (1) 532-538; DOI: https://doi.org/10.21873/invivo.13857
  • Open Access
    Precision Assessment of Anti-NMDA Receptor Encephalitis: A Case Report on Integrating Clinical Course, Immunophenotyping, and Comprehensive Symptomatology in a Pediatric Patient With Adjunctive Hydrogen Therapy
    SHANG-CHIANG LIN, JENG-WEI LU, TING-CHUN LIN, YUEH-FENG SUNG, YI-JUNG HO, FU-MIN WANG, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU
    In Vivo January 2025, 39 (1) 539-547; DOI: https://doi.org/10.21873/invivo.13858
  • Open Access
    Heart Failure Masked as Pulmonary Embolism in Non-adherent Patient With Atrial Fibrillation: Case Report and Analytical Review of the Literature
    GIAN JACOBS, KATE EMBLIN, UMESH KADAM, ROB DANIELS, MOHAMMAD ALALLAN and KINAN MOKBEL
    In Vivo January 2025, 39 (1) 548-558; DOI: https://doi.org/10.21873/invivo.13859
  • Open Access
    Appendiceal Neuroendocrine Tumor: Clinicopathologic Characteristics of Six Cases and Review of the Literature
    YESEUL KIM, YOU-NA SUNG, ANNA THERESE DATUIN, INHO JANG and JONGMIN SIM
    In Vivo January 2025, 39 (1) 559-565; DOI: https://doi.org/10.21873/invivo.13860
  • Open Access
    Transient Ischaemic Attack in a Patient With Conn Syndrome: A Case Report and Literature Review on the Importance of Identifying Secondary Hypertension
    DANIEL LEE, KATE EMBLIN, ROB DANIELS, TOMAZO JOSEPH KALLIS, MOHAMMAD ALALLAN and KINAN MOKBEL
    In Vivo January 2025, 39 (1) 566-571; DOI: https://doi.org/10.21873/invivo.13861
  • Open Access
    Molecular Hydrogen as a Potential Adjunctive Therapy to Improve Renal Function and Reduce Fatigue in an Elderly Patient With Chronic Comorbidities: A Case Report
    YUN-TING LIN, JENG-WEI LU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU
    In Vivo January 2025, 39 (1) 572-576; DOI: https://doi.org/10.21873/invivo.13862
Back to top
PreviousNext

In this issue

In Vivo: 39 (1)
In Vivo
Vol. 39, Issue 1
January-February 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Identification of a T2-hyperintense Perivascular Space in Brain Arteriovenous Malformations
  • Mammary Cancer Models: An Overview from the Past to the Future
  • In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models
  • Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma
  • Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
In Vivo

© 2026 In Vivo

Powered by HighWire